SlideShare a Scribd company logo
Investor Conference Call
Q3 2013 Results

October 31, 2013 / Marijn Dekkers, CEO
Disclaimer
This presentation may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management.
Various known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here.
These factors include those discussed in Bayer’s public reports which are
available on the Bayer website at www.bayer.com.
The company assumes no liability whatsoever to update these forward-looking
statements or to conform them to future events or developments.

Page 2 • Q3 2013 Investor Conference Call • Marijn Dekkers
Q3 2013 – Bayer Continues Encouraging
Business Development


Ongoing strong performance of Life Sciences, MaterialScience level
with prior-year quarter



New pharma product sales exceeding expectations, full-year target
raised to >€1.4bn



Earnings significantly impacted by negative currency effects



Full-year 2013 Group outlook maintained although increasingly
ambitious

Page 3 • Q3 2013 Investor Conference Call • Marijn Dekkers
Q3 2013 –
Encouraging Business Development
Sales

EBIT

in € million
% currency & portfolio adj.

9,661

EBITDA

Core EPS

in € million

adjusted**
in € million

in €

9,643
1,842

1,984
1.27

1,221

1.17

828

Q3’12*

Q3’13

+6%

Q3’12*

Q3’13

+47%

Page 4 • Q3 2013 Investor Conference Call • Marijn Dekkers

Q3’12*

Q3’13

+8%

Q3’12*

Q3’13

+9%
*Prior-year figures restated
**before special items
Q3 2013 – Regional Performance:
Growth Led By Emerging Economies
In € million, ∆% yoy Fx adjusted

Q3 2013 Group Sales by Region
Emerging
Economies¹
+9%

USA
+3%

20%

Emerging Economies
+1%

+18%

~1,500

40%

~1,400

+11%

31%

~500

9%
Western Europe
+5%

+6%
~400

Others²
+8%

Group €9,643m; +6%

Page 5 • Q3 2013 Investor Conference Call • Marijn Dekkers

Emerging
Asia³

Latin
America

Eastern
Europe

Africa &
Middle East

¹ Emerging economies include: Latin America, Asia w/o Japan, Australia,
New Zealand, Africa and Middle East incl. Turkey, Eastern Europe
² Others = Japan, Australia, New Zealand, Canada
³ Emerging Asia = Asia w/o Japan, Australia, New Zealand
Q3 2013 –
Cash Flow And Net Debt Development
Cash Flow in € million, Net Debt in € billion

Q3 2013 Cash Flow

GCF

NCF

Net Debt Development

Investments

oFCF

-€1.3bn

7.7

1,367

∆
y-o-y

9.0

1,728

514

1,214

+36%

-13%

+6%

-19%
June 30, 2013

Page 6 • Q3 2013 Investor Conference Call • Marijn Dekkers

Sep 30, 2013
Q3 2013 – HealthCare: Organic Growth
Driven by New Products and Consumer Care
In € million, ∆% yoy, () = Fx & portf. adjusted

Sales
Consumer
Health
-3% (+3%)

Earnings1

36%
1,924

Pharma
+3% (+11%)

1,392

2,818

Adj.
EBIT*

Adj.
EBITDA*
+5%

1,331

915

+8%

1,006

1,048 +4%

847
633

HealthCare €4,742m; +1% (+7%)
Price
0%

Volume
+8%

Fx
-8%

Page 7 • Q3 2013 Investor Conference Call • Marijn Dekkers

Portfolio
+1%

484

477

+7%

371

-1%

-1%
373

Q3‘12 Q3‘13

677

Q3‘12 Q3‘13

1

*before special items
Prior-year figures restated.
Q3 2013 – CropScience:
Good Start to the Season in Latin America
In € million, ∆% yoy, () = Fx & portf. adjusted

Sales
Environmental Science
+8% (+19%)
68 140

Earnings1
Crop Protection
+6% (+14%)

Adj.
EBIT*

Adj.
EBITDA*

1,504
224

+14%

197

Seeds
-30% (-30%)

115 +51%
76
CropScience €1,712m; +4% (+12%)
Price
+3%

Volume
+9%

Fx
-8%

Page 8 • Q3 2013 Investor Conference Call • Marijn Dekkers

Portfolio
+1%

Q3‘12 Q3‘13

Q3‘12 Q3‘13

1

*before special items
Prior-year figures restated.
Q3 2013 - MaterialScience:
On Prior-Year Level
In € million, ∆% yoy, () = Fx & portf. adjusted

Sales
Polycarbonates
-6% (-3%)

Earnings1
Polyurethanes
0% (+4%)

673

1,567
337

CAS**
-5% (+1%)

Adj.
EBIT*

Adj.
EBITDA*

346

+3%

486
174

IO***
-9% (-7%)

186

+7%

171

MaterialScience €2,897m; -3% (+1%)
Price
-1%

Volume
+2%

Fx
-4%

Page 9 • Q3 2013 Investor Conference Call • Marijn Dekkers

Portfolio
0%
*before special items

Q3‘12 Q3‘13
**CAS: Coatings, Adhesives, Specialties

Q3‘12

Q3‘13

*** IO: Industrial Operations
1 Prior-year figures restated.
FY 2013 Group Outlook Maintained
Although Increasingly Ambitious
Sales ∆ Fx and portfolio adjusted, EBITDA before special items

20121

2013E

Sales

€39.7bn

+4-5% to
~€40bn*

adj. EBITDA

€8.3bn

mid-single-digit %
increase

Core EPS

€5.30

high-single-digit %
increase

Page 10 • Q3 2013 Investor Conference Call • Marijn Dekkers

*Assuming average Fx rates of 9M 2013
Outlook depends on specific planning assumptions as detailed in the Annual Report
1 2012 figures restated
Investor Conference Call
Q3 2013 Results

October 31, 2013 / Marijn Dekkers, CEO

More Related Content

What's hot

FY/Q4 2015 Investor Conference Call Presentation Charts
FY/Q4 2015 Investor Conference Call Presentation ChartsFY/Q4 2015 Investor Conference Call Presentation Charts
FY/Q4 2015 Investor Conference Call Presentation Charts
Bayer
 
Q3 2015 Investor Conference Call Presentation
Q3 2015 Investor Conference Call PresentationQ3 2015 Investor Conference Call Presentation
Q3 2015 Investor Conference Call Presentation
Bayer
 
Q3 2014 Investor Conference Call Presentation Charts
Q3 2014 Investor Conference Call Presentation ChartsQ3 2014 Investor Conference Call Presentation Charts
Q3 2014 Investor Conference Call Presentation Charts
Bayer
 
Investor Conference Call 2014-09-18: Transforming Bayer into a Pure Life Scie...
Investor Conference Call 2014-09-18: Transforming Bayer into a Pure Life Scie...Investor Conference Call 2014-09-18: Transforming Bayer into a Pure Life Scie...
Investor Conference Call 2014-09-18: Transforming Bayer into a Pure Life Scie...
Bayer
 
Bayer Meet Management in London on September 30, 2014
Bayer Meet Management in London on September 30, 2014Bayer Meet Management in London on September 30, 2014
Bayer Meet Management in London on September 30, 2014
Bayer
 
Meet management 2013-10-08_investor_handout_web_slideshare
Meet management 2013-10-08_investor_handout_web_slideshareMeet management 2013-10-08_investor_handout_web_slideshare
Meet management 2013-10-08_investor_handout_web_slideshare
Bayer
 
Q2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Q2 2014 Investor Conference Call on 2014-07-30 Presentation ChartsQ2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Q2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Bayer
 
Investor Handout Meet Management 2014 in Leverkusen
Investor Handout Meet Management 2014 in LeverkusenInvestor Handout Meet Management 2014 in Leverkusen
Investor Handout Meet Management 2014 in Leverkusen
Bayer
 
Meet Management in London - Investor Handout March 2017
Meet Management in London - Investor Handout March 2017Meet Management in London - Investor Handout March 2017
Meet Management in London - Investor Handout March 2017
Bayer
 
Q2 2017 Investor Conference Call Presentation
Q2 2017 Investor Conference Call PresentationQ2 2017 Investor Conference Call Presentation
Q2 2017 Investor Conference Call Presentation
Bayer
 
Investor Handout Meet Management 2013 New York June 2013
Investor Handout Meet Management 2013 New York June 2013Investor Handout Meet Management 2013 New York June 2013
Investor Handout Meet Management 2013 New York June 2013
Bayer
 
Bayer AG Meet Management 2016 Investor Handout
Bayer AG Meet Management 2016 Investor HandoutBayer AG Meet Management 2016 Investor Handout
Bayer AG Meet Management 2016 Investor Handout
Bayer
 
Investors Presentation 9M|2020 Results
Investors Presentation 9M|2020 ResultsInvestors Presentation 9M|2020 Results
Investors Presentation 9M|2020 Results
AndreGro
 
Q2 2013 Investor Conference Call Presentation Charts
Q2 2013 Investor Conference Call Presentation ChartsQ2 2013 Investor Conference Call Presentation Charts
Q2 2013 Investor Conference Call Presentation Charts
Bayer
 
Bayer AG Q3 2010 Investor Handout
Bayer AG Q3 2010 Investor HandoutBayer AG Q3 2010 Investor Handout
Bayer AG Q3 2010 Investor Handout
Bayer
 
FY/Q4 2016 Investor Conference Call Presentation
FY/Q4 2016 Investor Conference Call PresentationFY/Q4 2016 Investor Conference Call Presentation
FY/Q4 2016 Investor Conference Call Presentation
Bayer
 
FY/Q4 Investor Conference Call Presentation
FY/Q4 Investor Conference Call PresentationFY/Q4 Investor Conference Call Presentation
FY/Q4 Investor Conference Call Presentation
Bayer
 
FY/Q4 2018 Investor Conference Call Presentation
FY/Q4 2018 Investor Conference Call PresentationFY/Q4 2018 Investor Conference Call Presentation
FY/Q4 2018 Investor Conference Call Presentation
Bayer
 

What's hot (18)

FY/Q4 2015 Investor Conference Call Presentation Charts
FY/Q4 2015 Investor Conference Call Presentation ChartsFY/Q4 2015 Investor Conference Call Presentation Charts
FY/Q4 2015 Investor Conference Call Presentation Charts
 
Q3 2015 Investor Conference Call Presentation
Q3 2015 Investor Conference Call PresentationQ3 2015 Investor Conference Call Presentation
Q3 2015 Investor Conference Call Presentation
 
Q3 2014 Investor Conference Call Presentation Charts
Q3 2014 Investor Conference Call Presentation ChartsQ3 2014 Investor Conference Call Presentation Charts
Q3 2014 Investor Conference Call Presentation Charts
 
Investor Conference Call 2014-09-18: Transforming Bayer into a Pure Life Scie...
Investor Conference Call 2014-09-18: Transforming Bayer into a Pure Life Scie...Investor Conference Call 2014-09-18: Transforming Bayer into a Pure Life Scie...
Investor Conference Call 2014-09-18: Transforming Bayer into a Pure Life Scie...
 
Bayer Meet Management in London on September 30, 2014
Bayer Meet Management in London on September 30, 2014Bayer Meet Management in London on September 30, 2014
Bayer Meet Management in London on September 30, 2014
 
Meet management 2013-10-08_investor_handout_web_slideshare
Meet management 2013-10-08_investor_handout_web_slideshareMeet management 2013-10-08_investor_handout_web_slideshare
Meet management 2013-10-08_investor_handout_web_slideshare
 
Q2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Q2 2014 Investor Conference Call on 2014-07-30 Presentation ChartsQ2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
Q2 2014 Investor Conference Call on 2014-07-30 Presentation Charts
 
Investor Handout Meet Management 2014 in Leverkusen
Investor Handout Meet Management 2014 in LeverkusenInvestor Handout Meet Management 2014 in Leverkusen
Investor Handout Meet Management 2014 in Leverkusen
 
Meet Management in London - Investor Handout March 2017
Meet Management in London - Investor Handout March 2017Meet Management in London - Investor Handout March 2017
Meet Management in London - Investor Handout March 2017
 
Q2 2017 Investor Conference Call Presentation
Q2 2017 Investor Conference Call PresentationQ2 2017 Investor Conference Call Presentation
Q2 2017 Investor Conference Call Presentation
 
Investor Handout Meet Management 2013 New York June 2013
Investor Handout Meet Management 2013 New York June 2013Investor Handout Meet Management 2013 New York June 2013
Investor Handout Meet Management 2013 New York June 2013
 
Bayer AG Meet Management 2016 Investor Handout
Bayer AG Meet Management 2016 Investor HandoutBayer AG Meet Management 2016 Investor Handout
Bayer AG Meet Management 2016 Investor Handout
 
Investors Presentation 9M|2020 Results
Investors Presentation 9M|2020 ResultsInvestors Presentation 9M|2020 Results
Investors Presentation 9M|2020 Results
 
Q2 2013 Investor Conference Call Presentation Charts
Q2 2013 Investor Conference Call Presentation ChartsQ2 2013 Investor Conference Call Presentation Charts
Q2 2013 Investor Conference Call Presentation Charts
 
Bayer AG Q3 2010 Investor Handout
Bayer AG Q3 2010 Investor HandoutBayer AG Q3 2010 Investor Handout
Bayer AG Q3 2010 Investor Handout
 
FY/Q4 2016 Investor Conference Call Presentation
FY/Q4 2016 Investor Conference Call PresentationFY/Q4 2016 Investor Conference Call Presentation
FY/Q4 2016 Investor Conference Call Presentation
 
FY/Q4 Investor Conference Call Presentation
FY/Q4 Investor Conference Call PresentationFY/Q4 Investor Conference Call Presentation
FY/Q4 Investor Conference Call Presentation
 
FY/Q4 2018 Investor Conference Call Presentation
FY/Q4 2018 Investor Conference Call PresentationFY/Q4 2018 Investor Conference Call Presentation
FY/Q4 2018 Investor Conference Call Presentation
 

Similar to Q3 2013 Investor Conference Call Presentation slides

Q1 2013 Investor Conference Call Presentation Charts
Q1 2013 Investor Conference Call Presentation ChartsQ1 2013 Investor Conference Call Presentation Charts
Q1 2013 Investor Conference Call Presentation Charts
Bayer
 
Merck Q3 2013 Results Press Conference
Merck Q3 2013 Results Press ConferenceMerck Q3 2013 Results Press Conference
Merck Q3 2013 Results Press Conference
Merck
 
Q2 2013 Earnings Presentation - Merck
Q2 2013 Earnings Presentation - Merck Q2 2013 Earnings Presentation - Merck
Q2 2013 Earnings Presentation - Merck
Merck
 
Merck: Q2 2014 Results Conference Call
Merck: Q2 2014 Results Conference CallMerck: Q2 2014 Results Conference Call
Merck: Q2 2014 Results Conference Call
Merck
 
BRF S.A Anual Sales Report 2015
BRF S.A Anual Sales Report 2015BRF S.A Anual Sales Report 2015
BRF S.A Anual Sales Report 2015
BRF FOODS S.A BRAZIL
 
Q4 2013 Earnings Presentation
Q4 2013 Earnings PresentationQ4 2013 Earnings Presentation
Q4 2013 Earnings Presentation
InvestorBruker
 
Bayer Q2 2009 Results
Bayer Q2 2009 ResultsBayer Q2 2009 Results
Bayer Q2 2009 Results
investorrelation
 
Kloeckner & Co Analysts and Investor Presentation 3rd Quarter results 2014
Kloeckner & Co Analysts and Investor Presentation 3rd Quarter results 2014Kloeckner & Co Analysts and Investor Presentation 3rd Quarter results 2014
Kloeckner & Co Analysts and Investor Presentation 3rd Quarter results 2014
Klöckner & Co SE
 
SGS 2022 Half Year Results Report
SGS 2022 Half Year Results ReportSGS 2022 Half Year Results Report
SGS 2022 Half Year Results Report
SGS
 
2013 Half Year Results Analyst Presentation
2013 Half Year Results Analyst Presentation2013 Half Year Results Analyst Presentation
2013 Half Year Results Analyst Presentation
Syngenta
 
Merck: Q1 2014 Results Conference Call
Merck: Q1 2014 Results Conference Call Merck: Q1 2014 Results Conference Call
Merck: Q1 2014 Results Conference Call
Merck
 
Azure healthcare-annual-report 2013
Azure healthcare-annual-report 2013Azure healthcare-annual-report 2013
Azure healthcare-annual-report 2013
Sazzad Hossain, ITP, MBA, CSCA™
 
Aegon's Q1 2013 results
Aegon's Q1 2013 resultsAegon's Q1 2013 results
Aegon's Q1 2013 results
Aegon
 
SGS 2023 Full Year Results Earnings Release EN.pdf
SGS 2023 Full Year Results Earnings Release EN.pdfSGS 2023 Full Year Results Earnings Release EN.pdf
SGS 2023 Full Year Results Earnings Release EN.pdf
SGS
 
Q3 2019 Investor Conference Call Presentation
Q3 2019 Investor Conference Call PresentationQ3 2019 Investor Conference Call Presentation
Q3 2019 Investor Conference Call Presentation
Bayer
 
Merck: Annual Press Conference 2013
Merck: Annual Press Conference 2013Merck: Annual Press Conference 2013
Merck: Annual Press Conference 2013
Merck
 
Gunnebo Interim Report January-June 2013
Gunnebo Interim Report January-June 2013Gunnebo Interim Report January-June 2013
Gunnebo Interim Report January-June 2013
Gunnebo Group
 
SGS 2022 Full Year Results Report
SGS 2022 Full Year Results ReportSGS 2022 Full Year Results Report
SGS 2022 Full Year Results Report
SGS
 
2015 AGM Presentation
2015 AGM Presentation2015 AGM Presentation
2015 AGM Presentation
Aegon
 
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Bayer
 

Similar to Q3 2013 Investor Conference Call Presentation slides (20)

Q1 2013 Investor Conference Call Presentation Charts
Q1 2013 Investor Conference Call Presentation ChartsQ1 2013 Investor Conference Call Presentation Charts
Q1 2013 Investor Conference Call Presentation Charts
 
Merck Q3 2013 Results Press Conference
Merck Q3 2013 Results Press ConferenceMerck Q3 2013 Results Press Conference
Merck Q3 2013 Results Press Conference
 
Q2 2013 Earnings Presentation - Merck
Q2 2013 Earnings Presentation - Merck Q2 2013 Earnings Presentation - Merck
Q2 2013 Earnings Presentation - Merck
 
Merck: Q2 2014 Results Conference Call
Merck: Q2 2014 Results Conference CallMerck: Q2 2014 Results Conference Call
Merck: Q2 2014 Results Conference Call
 
BRF S.A Anual Sales Report 2015
BRF S.A Anual Sales Report 2015BRF S.A Anual Sales Report 2015
BRF S.A Anual Sales Report 2015
 
Q4 2013 Earnings Presentation
Q4 2013 Earnings PresentationQ4 2013 Earnings Presentation
Q4 2013 Earnings Presentation
 
Bayer Q2 2009 Results
Bayer Q2 2009 ResultsBayer Q2 2009 Results
Bayer Q2 2009 Results
 
Kloeckner & Co Analysts and Investor Presentation 3rd Quarter results 2014
Kloeckner & Co Analysts and Investor Presentation 3rd Quarter results 2014Kloeckner & Co Analysts and Investor Presentation 3rd Quarter results 2014
Kloeckner & Co Analysts and Investor Presentation 3rd Quarter results 2014
 
SGS 2022 Half Year Results Report
SGS 2022 Half Year Results ReportSGS 2022 Half Year Results Report
SGS 2022 Half Year Results Report
 
2013 Half Year Results Analyst Presentation
2013 Half Year Results Analyst Presentation2013 Half Year Results Analyst Presentation
2013 Half Year Results Analyst Presentation
 
Merck: Q1 2014 Results Conference Call
Merck: Q1 2014 Results Conference Call Merck: Q1 2014 Results Conference Call
Merck: Q1 2014 Results Conference Call
 
Azure healthcare-annual-report 2013
Azure healthcare-annual-report 2013Azure healthcare-annual-report 2013
Azure healthcare-annual-report 2013
 
Aegon's Q1 2013 results
Aegon's Q1 2013 resultsAegon's Q1 2013 results
Aegon's Q1 2013 results
 
SGS 2023 Full Year Results Earnings Release EN.pdf
SGS 2023 Full Year Results Earnings Release EN.pdfSGS 2023 Full Year Results Earnings Release EN.pdf
SGS 2023 Full Year Results Earnings Release EN.pdf
 
Q3 2019 Investor Conference Call Presentation
Q3 2019 Investor Conference Call PresentationQ3 2019 Investor Conference Call Presentation
Q3 2019 Investor Conference Call Presentation
 
Merck: Annual Press Conference 2013
Merck: Annual Press Conference 2013Merck: Annual Press Conference 2013
Merck: Annual Press Conference 2013
 
Gunnebo Interim Report January-June 2013
Gunnebo Interim Report January-June 2013Gunnebo Interim Report January-June 2013
Gunnebo Interim Report January-June 2013
 
SGS 2022 Full Year Results Report
SGS 2022 Full Year Results ReportSGS 2022 Full Year Results Report
SGS 2022 Full Year Results Report
 
2015 AGM Presentation
2015 AGM Presentation2015 AGM Presentation
2015 AGM Presentation
 
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
Presentation for Bayer's Q1 2020 Investor Con-ference Call on April 27, 2020
 

More from Bayer

Q3 2023 Investor Webinar Presentation
Q3 2023 Investor Webinar PresentationQ3 2023 Investor Webinar Presentation
Q3 2023 Investor Webinar Presentation
Bayer
 
Q2 2023 Investor Webinar Presentation
Q2 2023 Investor Webinar PresentationQ2 2023 Investor Webinar Presentation
Q2 2023 Investor Webinar Presentation
Bayer
 
Q1 2023 Investor Conference Call Presentation
Q1 2023 Investor Conference Call PresentationQ1 2023 Investor Conference Call Presentation
Q1 2023 Investor Conference Call Presentation
Bayer
 
Q3 2022 Investor Conference Call Presentation
Q3 2022 Investor Conference Call PresentationQ3 2022 Investor Conference Call Presentation
Q3 2022 Investor Conference Call Presentation
Bayer
 
Q2 2022 Investor Conference Call Presentation
Q2 2022 Investor Conference Call PresentationQ2 2022 Investor Conference Call Presentation
Q2 2022 Investor Conference Call Presentation
Bayer
 
Q1 2022 Investor Conference Call Presentation
Q1 2022 Investor Conference Call PresentationQ1 2022 Investor Conference Call Presentation
Q1 2022 Investor Conference Call Presentation
Bayer
 
FY/Q4 2021 Investor Conference Call Presentation
FY/Q4 2021 Investor Conference Call PresentationFY/Q4 2021 Investor Conference Call Presentation
FY/Q4 2021 Investor Conference Call Presentation
Bayer
 
Q3 2021 Investor Conference Call Presentation
Q3 2021 Investor Conference Call PresentationQ3 2021 Investor Conference Call Presentation
Q3 2021 Investor Conference Call Presentation
Bayer
 
Q2 2021 Investor Conference Call Presentation
Q2 2021 Investor Conference Call PresentationQ2 2021 Investor Conference Call Presentation
Q2 2021 Investor Conference Call Presentation
Bayer
 
Q1 2021 Investor Conference Call Presentation
Q1 2021 Investor Conference Call PresentationQ1 2021 Investor Conference Call Presentation
Q1 2021 Investor Conference Call Presentation
Bayer
 
Q3 2020 Investor Conference Call Presentation
Q3 2020 Investor Conference Call PresentationQ3 2020 Investor Conference Call Presentation
Q3 2020 Investor Conference Call Presentation
Bayer
 
Q2 2020 Investor Conference Call Presentation
Q2 2020 Investor Conference Call PresentationQ2 2020 Investor Conference Call Presentation
Q2 2020 Investor Conference Call Presentation
Bayer
 
FY/Q4 2019 Investor Conference Call Presentation
FY/Q4 2019 Investor Conference Call PresentationFY/Q4 2019 Investor Conference Call Presentation
FY/Q4 2019 Investor Conference Call Presentation
Bayer
 
Investor Conference Call Presentation: Crop Science R&D Pipeline Update
Investor Conference Call Presentation:  Crop Science R&D Pipeline UpdateInvestor Conference Call Presentation:  Crop Science R&D Pipeline Update
Investor Conference Call Presentation: Crop Science R&D Pipeline Update
Bayer
 
Investor Conference Call Presentation: Bayer 2030 Sustainable Development Ob...
Investor Conference Call Presentation:  Bayer 2030 Sustainable Development Ob...Investor Conference Call Presentation:  Bayer 2030 Sustainable Development Ob...
Investor Conference Call Presentation: Bayer 2030 Sustainable Development Ob...
Bayer
 
Crop Science Summer Technology Showcase August 1, 2019
Crop Science Summer Technology Showcase August 1, 2019Crop Science Summer Technology Showcase August 1, 2019
Crop Science Summer Technology Showcase August 1, 2019
Bayer
 
Q2 2019 Investor Conference Call Presentation
Q2 2019 Investor Conference Call PresentationQ2 2019 Investor Conference Call Presentation
Q2 2019 Investor Conference Call Presentation
Bayer
 
Q1 2019 Investor Conference Call Presentation
Q1 2019 Investor Conference Call PresentationQ1 2019 Investor Conference Call Presentation
Q1 2019 Investor Conference Call Presentation
Bayer
 
Capital Markets Day in London - Investor Handout December 2018
Capital Markets Day in London - Investor Handout December 2018Capital Markets Day in London - Investor Handout December 2018
Capital Markets Day in London - Investor Handout December 2018
Bayer
 
Q3 2018 Investor Conference Call Presentation
Q3 2018 Investor Conference Call PresentationQ3 2018 Investor Conference Call Presentation
Q3 2018 Investor Conference Call Presentation
Bayer
 

More from Bayer (20)

Q3 2023 Investor Webinar Presentation
Q3 2023 Investor Webinar PresentationQ3 2023 Investor Webinar Presentation
Q3 2023 Investor Webinar Presentation
 
Q2 2023 Investor Webinar Presentation
Q2 2023 Investor Webinar PresentationQ2 2023 Investor Webinar Presentation
Q2 2023 Investor Webinar Presentation
 
Q1 2023 Investor Conference Call Presentation
Q1 2023 Investor Conference Call PresentationQ1 2023 Investor Conference Call Presentation
Q1 2023 Investor Conference Call Presentation
 
Q3 2022 Investor Conference Call Presentation
Q3 2022 Investor Conference Call PresentationQ3 2022 Investor Conference Call Presentation
Q3 2022 Investor Conference Call Presentation
 
Q2 2022 Investor Conference Call Presentation
Q2 2022 Investor Conference Call PresentationQ2 2022 Investor Conference Call Presentation
Q2 2022 Investor Conference Call Presentation
 
Q1 2022 Investor Conference Call Presentation
Q1 2022 Investor Conference Call PresentationQ1 2022 Investor Conference Call Presentation
Q1 2022 Investor Conference Call Presentation
 
FY/Q4 2021 Investor Conference Call Presentation
FY/Q4 2021 Investor Conference Call PresentationFY/Q4 2021 Investor Conference Call Presentation
FY/Q4 2021 Investor Conference Call Presentation
 
Q3 2021 Investor Conference Call Presentation
Q3 2021 Investor Conference Call PresentationQ3 2021 Investor Conference Call Presentation
Q3 2021 Investor Conference Call Presentation
 
Q2 2021 Investor Conference Call Presentation
Q2 2021 Investor Conference Call PresentationQ2 2021 Investor Conference Call Presentation
Q2 2021 Investor Conference Call Presentation
 
Q1 2021 Investor Conference Call Presentation
Q1 2021 Investor Conference Call PresentationQ1 2021 Investor Conference Call Presentation
Q1 2021 Investor Conference Call Presentation
 
Q3 2020 Investor Conference Call Presentation
Q3 2020 Investor Conference Call PresentationQ3 2020 Investor Conference Call Presentation
Q3 2020 Investor Conference Call Presentation
 
Q2 2020 Investor Conference Call Presentation
Q2 2020 Investor Conference Call PresentationQ2 2020 Investor Conference Call Presentation
Q2 2020 Investor Conference Call Presentation
 
FY/Q4 2019 Investor Conference Call Presentation
FY/Q4 2019 Investor Conference Call PresentationFY/Q4 2019 Investor Conference Call Presentation
FY/Q4 2019 Investor Conference Call Presentation
 
Investor Conference Call Presentation: Crop Science R&D Pipeline Update
Investor Conference Call Presentation:  Crop Science R&D Pipeline UpdateInvestor Conference Call Presentation:  Crop Science R&D Pipeline Update
Investor Conference Call Presentation: Crop Science R&D Pipeline Update
 
Investor Conference Call Presentation: Bayer 2030 Sustainable Development Ob...
Investor Conference Call Presentation:  Bayer 2030 Sustainable Development Ob...Investor Conference Call Presentation:  Bayer 2030 Sustainable Development Ob...
Investor Conference Call Presentation: Bayer 2030 Sustainable Development Ob...
 
Crop Science Summer Technology Showcase August 1, 2019
Crop Science Summer Technology Showcase August 1, 2019Crop Science Summer Technology Showcase August 1, 2019
Crop Science Summer Technology Showcase August 1, 2019
 
Q2 2019 Investor Conference Call Presentation
Q2 2019 Investor Conference Call PresentationQ2 2019 Investor Conference Call Presentation
Q2 2019 Investor Conference Call Presentation
 
Q1 2019 Investor Conference Call Presentation
Q1 2019 Investor Conference Call PresentationQ1 2019 Investor Conference Call Presentation
Q1 2019 Investor Conference Call Presentation
 
Capital Markets Day in London - Investor Handout December 2018
Capital Markets Day in London - Investor Handout December 2018Capital Markets Day in London - Investor Handout December 2018
Capital Markets Day in London - Investor Handout December 2018
 
Q3 2018 Investor Conference Call Presentation
Q3 2018 Investor Conference Call PresentationQ3 2018 Investor Conference Call Presentation
Q3 2018 Investor Conference Call Presentation
 

Recently uploaded

A Complete Guide of Dubai Freelance Visa and Permit in 2024
A Complete Guide of Dubai Freelance Visa and Permit in 2024A Complete Guide of Dubai Freelance Visa and Permit in 2024
A Complete Guide of Dubai Freelance Visa and Permit in 2024
Dubiz
 
Retail Store Scavenger Hunt powerpoint slides
Retail Store Scavenger Hunt powerpoint slidesRetail Store Scavenger Hunt powerpoint slides
Retail Store Scavenger Hunt powerpoint slides
JairSemexant
 
PETAVIT MICHAEL TAY.pdfAAAAAAAAAAAAAAAAAAAA
PETAVIT MICHAEL TAY.pdfAAAAAAAAAAAAAAAAAAAAPETAVIT MICHAEL TAY.pdfAAAAAAAAAAAAAAAAAAAA
PETAVIT MICHAEL TAY.pdfAAAAAAAAAAAAAAAAAAAA
lawrenceads01
 
foodgasm restaurant and Bar pune road.docx
foodgasm restaurant and Bar pune road.docxfoodgasm restaurant and Bar pune road.docx
foodgasm restaurant and Bar pune road.docx
PraghyaBhandari
 
Cheslyn Jacobs- TymeBank: Building Consumer Trust in Digital Banking
Cheslyn Jacobs- TymeBank: Building Consumer Trust in Digital  BankingCheslyn Jacobs- TymeBank: Building Consumer Trust in Digital  Banking
Cheslyn Jacobs- TymeBank: Building Consumer Trust in Digital Banking
itnewsafrica
 
Zodiac Signs and Fashion: Dressing to Suit Your Astrological Style
Zodiac Signs and Fashion: Dressing to Suit Your Astrological StyleZodiac Signs and Fashion: Dressing to Suit Your Astrological Style
Zodiac Signs and Fashion: Dressing to Suit Your Astrological Style
my Pandit
 
You Get Me! Leveraging Communication Styles in Virtual Trainingpptx
You Get Me! Leveraging Communication Styles in Virtual TrainingpptxYou Get Me! Leveraging Communication Styles in Virtual Trainingpptx
You Get Me! Leveraging Communication Styles in Virtual Trainingpptx
Cynthia Clay
 
WAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdfWAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdf
Western Alaska Minerals Corp.
 
Cracking the Customer Experience Code.pptx
Cracking the Customer Experience Code.pptxCracking the Customer Experience Code.pptx
Cracking the Customer Experience Code.pptx
Workforce Group
 
Satta matka guessing Kalyan result sattamatka
Satta matka guessing Kalyan result sattamatkaSatta matka guessing Kalyan result sattamatka
Satta matka guessing Kalyan result sattamatka
➑➌➋➑➒➎➑➑➊➍
 
Green Minimalist Aesthetic Project Proposal Presentation.pdf
Green Minimalist Aesthetic Project Proposal Presentation.pdfGreen Minimalist Aesthetic Project Proposal Presentation.pdf
Green Minimalist Aesthetic Project Proposal Presentation.pdf
shivamkush646
 
Easy Approval Same Day Emergency Cash Loans for Urgent Situations
Easy Approval Same Day Emergency Cash Loans for Urgent SituationsEasy Approval Same Day Emergency Cash Loans for Urgent Situations
Easy Approval Same Day Emergency Cash Loans for Urgent Situations
EiLoan
 
The Most Innovative Blockchain Company to Follow in 2024 (5).pdf
The Most Innovative Blockchain Company to Follow in 2024 (5).pdfThe Most Innovative Blockchain Company to Follow in 2024 (5).pdf
The Most Innovative Blockchain Company to Follow in 2024 (5).pdf
analyticsinsightmaga
 
STEPIC Innovations 2026 futurism publications
STEPIC Innovations 2026 futurism publicationsSTEPIC Innovations 2026 futurism publications
STEPIC Innovations 2026 futurism publications
mcynthus
 
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Philip M Caputo
 
BBA Final SML 501 INTERNATIONAL BUSINESS .pdf
BBA Final SML 501 INTERNATIONAL BUSINESS .pdfBBA Final SML 501 INTERNATIONAL BUSINESS .pdf
BBA Final SML 501 INTERNATIONAL BUSINESS .pdf
mcdopex6
 
PETAVIT SIP-05.pdfAAAAAAAAAAAAAAAAAAAAAAAAA
PETAVIT SIP-05.pdfAAAAAAAAAAAAAAAAAAAAAAAAAPETAVIT SIP-05.pdfAAAAAAAAAAAAAAAAAAAAAAAAA
PETAVIT SIP-05.pdfAAAAAAAAAAAAAAAAAAAAAAAAA
lawrenceads01
 
WAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdfWAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdf
Western Alaska Minerals Corp.
 
TALENT ACQUISITION AND MANAGEMENT LECTURE 2
TALENT ACQUISITION AND MANAGEMENT LECTURE 2TALENT ACQUISITION AND MANAGEMENT LECTURE 2
TALENT ACQUISITION AND MANAGEMENT LECTURE 2
projectseasy
 
Test Bank For Principles Of Cost Accounting, 17th Edition Edward J. Vander...
Test Bank For Principles Of Cost Accounting, 	  17th Edition Edward J. Vander...Test Bank For Principles Of Cost Accounting, 	  17th Edition Edward J. Vander...
Test Bank For Principles Of Cost Accounting, 17th Edition Edward J. Vander...
kevinkariuki227
 

Recently uploaded (20)

A Complete Guide of Dubai Freelance Visa and Permit in 2024
A Complete Guide of Dubai Freelance Visa and Permit in 2024A Complete Guide of Dubai Freelance Visa and Permit in 2024
A Complete Guide of Dubai Freelance Visa and Permit in 2024
 
Retail Store Scavenger Hunt powerpoint slides
Retail Store Scavenger Hunt powerpoint slidesRetail Store Scavenger Hunt powerpoint slides
Retail Store Scavenger Hunt powerpoint slides
 
PETAVIT MICHAEL TAY.pdfAAAAAAAAAAAAAAAAAAAA
PETAVIT MICHAEL TAY.pdfAAAAAAAAAAAAAAAAAAAAPETAVIT MICHAEL TAY.pdfAAAAAAAAAAAAAAAAAAAA
PETAVIT MICHAEL TAY.pdfAAAAAAAAAAAAAAAAAAAA
 
foodgasm restaurant and Bar pune road.docx
foodgasm restaurant and Bar pune road.docxfoodgasm restaurant and Bar pune road.docx
foodgasm restaurant and Bar pune road.docx
 
Cheslyn Jacobs- TymeBank: Building Consumer Trust in Digital Banking
Cheslyn Jacobs- TymeBank: Building Consumer Trust in Digital  BankingCheslyn Jacobs- TymeBank: Building Consumer Trust in Digital  Banking
Cheslyn Jacobs- TymeBank: Building Consumer Trust in Digital Banking
 
Zodiac Signs and Fashion: Dressing to Suit Your Astrological Style
Zodiac Signs and Fashion: Dressing to Suit Your Astrological StyleZodiac Signs and Fashion: Dressing to Suit Your Astrological Style
Zodiac Signs and Fashion: Dressing to Suit Your Astrological Style
 
You Get Me! Leveraging Communication Styles in Virtual Trainingpptx
You Get Me! Leveraging Communication Styles in Virtual TrainingpptxYou Get Me! Leveraging Communication Styles in Virtual Trainingpptx
You Get Me! Leveraging Communication Styles in Virtual Trainingpptx
 
WAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdfWAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdf
 
Cracking the Customer Experience Code.pptx
Cracking the Customer Experience Code.pptxCracking the Customer Experience Code.pptx
Cracking the Customer Experience Code.pptx
 
Satta matka guessing Kalyan result sattamatka
Satta matka guessing Kalyan result sattamatkaSatta matka guessing Kalyan result sattamatka
Satta matka guessing Kalyan result sattamatka
 
Green Minimalist Aesthetic Project Proposal Presentation.pdf
Green Minimalist Aesthetic Project Proposal Presentation.pdfGreen Minimalist Aesthetic Project Proposal Presentation.pdf
Green Minimalist Aesthetic Project Proposal Presentation.pdf
 
Easy Approval Same Day Emergency Cash Loans for Urgent Situations
Easy Approval Same Day Emergency Cash Loans for Urgent SituationsEasy Approval Same Day Emergency Cash Loans for Urgent Situations
Easy Approval Same Day Emergency Cash Loans for Urgent Situations
 
The Most Innovative Blockchain Company to Follow in 2024 (5).pdf
The Most Innovative Blockchain Company to Follow in 2024 (5).pdfThe Most Innovative Blockchain Company to Follow in 2024 (5).pdf
The Most Innovative Blockchain Company to Follow in 2024 (5).pdf
 
STEPIC Innovations 2026 futurism publications
STEPIC Innovations 2026 futurism publicationsSTEPIC Innovations 2026 futurism publications
STEPIC Innovations 2026 futurism publications
 
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
Innovation Hub_ Spotlight on Toms River's Role as a Beacon for Entrepreneuria...
 
BBA Final SML 501 INTERNATIONAL BUSINESS .pdf
BBA Final SML 501 INTERNATIONAL BUSINESS .pdfBBA Final SML 501 INTERNATIONAL BUSINESS .pdf
BBA Final SML 501 INTERNATIONAL BUSINESS .pdf
 
PETAVIT SIP-05.pdfAAAAAAAAAAAAAAAAAAAAAAAAA
PETAVIT SIP-05.pdfAAAAAAAAAAAAAAAAAAAAAAAAAPETAVIT SIP-05.pdfAAAAAAAAAAAAAAAAAAAAAAAAA
PETAVIT SIP-05.pdfAAAAAAAAAAAAAAAAAAAAAAAAA
 
WAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdfWAM Corporate Presentation July 2024.pdf
WAM Corporate Presentation July 2024.pdf
 
TALENT ACQUISITION AND MANAGEMENT LECTURE 2
TALENT ACQUISITION AND MANAGEMENT LECTURE 2TALENT ACQUISITION AND MANAGEMENT LECTURE 2
TALENT ACQUISITION AND MANAGEMENT LECTURE 2
 
Test Bank For Principles Of Cost Accounting, 17th Edition Edward J. Vander...
Test Bank For Principles Of Cost Accounting, 	  17th Edition Edward J. Vander...Test Bank For Principles Of Cost Accounting, 	  17th Edition Edward J. Vander...
Test Bank For Principles Of Cost Accounting, 17th Edition Edward J. Vander...
 

Q3 2013 Investor Conference Call Presentation slides

  • 1. Investor Conference Call Q3 2013 Results October 31, 2013 / Marijn Dekkers, CEO
  • 2. Disclaimer This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. Page 2 • Q3 2013 Investor Conference Call • Marijn Dekkers
  • 3. Q3 2013 – Bayer Continues Encouraging Business Development  Ongoing strong performance of Life Sciences, MaterialScience level with prior-year quarter  New pharma product sales exceeding expectations, full-year target raised to >€1.4bn  Earnings significantly impacted by negative currency effects  Full-year 2013 Group outlook maintained although increasingly ambitious Page 3 • Q3 2013 Investor Conference Call • Marijn Dekkers
  • 4. Q3 2013 – Encouraging Business Development Sales EBIT in € million % currency & portfolio adj. 9,661 EBITDA Core EPS in € million adjusted** in € million in € 9,643 1,842 1,984 1.27 1,221 1.17 828 Q3’12* Q3’13 +6% Q3’12* Q3’13 +47% Page 4 • Q3 2013 Investor Conference Call • Marijn Dekkers Q3’12* Q3’13 +8% Q3’12* Q3’13 +9% *Prior-year figures restated **before special items
  • 5. Q3 2013 – Regional Performance: Growth Led By Emerging Economies In € million, ∆% yoy Fx adjusted Q3 2013 Group Sales by Region Emerging Economies¹ +9% USA +3% 20% Emerging Economies +1% +18% ~1,500 40% ~1,400 +11% 31% ~500 9% Western Europe +5% +6% ~400 Others² +8% Group €9,643m; +6% Page 5 • Q3 2013 Investor Conference Call • Marijn Dekkers Emerging Asia³ Latin America Eastern Europe Africa & Middle East ¹ Emerging economies include: Latin America, Asia w/o Japan, Australia, New Zealand, Africa and Middle East incl. Turkey, Eastern Europe ² Others = Japan, Australia, New Zealand, Canada ³ Emerging Asia = Asia w/o Japan, Australia, New Zealand
  • 6. Q3 2013 – Cash Flow And Net Debt Development Cash Flow in € million, Net Debt in € billion Q3 2013 Cash Flow GCF NCF Net Debt Development Investments oFCF -€1.3bn 7.7 1,367 ∆ y-o-y 9.0 1,728 514 1,214 +36% -13% +6% -19% June 30, 2013 Page 6 • Q3 2013 Investor Conference Call • Marijn Dekkers Sep 30, 2013
  • 7. Q3 2013 – HealthCare: Organic Growth Driven by New Products and Consumer Care In € million, ∆% yoy, () = Fx & portf. adjusted Sales Consumer Health -3% (+3%) Earnings1 36% 1,924 Pharma +3% (+11%) 1,392 2,818 Adj. EBIT* Adj. EBITDA* +5% 1,331 915 +8% 1,006 1,048 +4% 847 633 HealthCare €4,742m; +1% (+7%) Price 0% Volume +8% Fx -8% Page 7 • Q3 2013 Investor Conference Call • Marijn Dekkers Portfolio +1% 484 477 +7% 371 -1% -1% 373 Q3‘12 Q3‘13 677 Q3‘12 Q3‘13 1 *before special items Prior-year figures restated.
  • 8. Q3 2013 – CropScience: Good Start to the Season in Latin America In € million, ∆% yoy, () = Fx & portf. adjusted Sales Environmental Science +8% (+19%) 68 140 Earnings1 Crop Protection +6% (+14%) Adj. EBIT* Adj. EBITDA* 1,504 224 +14% 197 Seeds -30% (-30%) 115 +51% 76 CropScience €1,712m; +4% (+12%) Price +3% Volume +9% Fx -8% Page 8 • Q3 2013 Investor Conference Call • Marijn Dekkers Portfolio +1% Q3‘12 Q3‘13 Q3‘12 Q3‘13 1 *before special items Prior-year figures restated.
  • 9. Q3 2013 - MaterialScience: On Prior-Year Level In € million, ∆% yoy, () = Fx & portf. adjusted Sales Polycarbonates -6% (-3%) Earnings1 Polyurethanes 0% (+4%) 673 1,567 337 CAS** -5% (+1%) Adj. EBIT* Adj. EBITDA* 346 +3% 486 174 IO*** -9% (-7%) 186 +7% 171 MaterialScience €2,897m; -3% (+1%) Price -1% Volume +2% Fx -4% Page 9 • Q3 2013 Investor Conference Call • Marijn Dekkers Portfolio 0% *before special items Q3‘12 Q3‘13 **CAS: Coatings, Adhesives, Specialties Q3‘12 Q3‘13 *** IO: Industrial Operations 1 Prior-year figures restated.
  • 10. FY 2013 Group Outlook Maintained Although Increasingly Ambitious Sales ∆ Fx and portfolio adjusted, EBITDA before special items 20121 2013E Sales €39.7bn +4-5% to ~€40bn* adj. EBITDA €8.3bn mid-single-digit % increase Core EPS €5.30 high-single-digit % increase Page 10 • Q3 2013 Investor Conference Call • Marijn Dekkers *Assuming average Fx rates of 9M 2013 Outlook depends on specific planning assumptions as detailed in the Annual Report 1 2012 figures restated
  • 11. Investor Conference Call Q3 2013 Results October 31, 2013 / Marijn Dekkers, CEO